ATE82860T1 - Thrombolytisches agens. - Google Patents

Thrombolytisches agens.

Info

Publication number
ATE82860T1
ATE82860T1 AT88114903T AT88114903T ATE82860T1 AT E82860 T1 ATE82860 T1 AT E82860T1 AT 88114903 T AT88114903 T AT 88114903T AT 88114903 T AT88114903 T AT 88114903T AT E82860 T1 ATE82860 T1 AT E82860T1
Authority
AT
Austria
Prior art keywords
thrombolytic agent
urokinase
plasminogen
lys
pro
Prior art date
Application number
AT88114903T
Other languages
English (en)
Inventor
Vijay Vir Kakkar
Michael Finbarr Scully
Vincent John Ellis
Yoichi Watahiki
Original Assignee
Thrombosis Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thrombosis Res Inst filed Critical Thrombosis Res Inst
Application granted granted Critical
Publication of ATE82860T1 publication Critical patent/ATE82860T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88114903T 1987-09-18 1988-09-13 Thrombolytisches agens. ATE82860T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878721951A GB8721951D0 (en) 1987-09-18 1987-09-18 Organic compounds
EP88114903A EP0307847B1 (de) 1987-09-18 1988-09-13 Thrombolytisches Agens

Publications (1)

Publication Number Publication Date
ATE82860T1 true ATE82860T1 (de) 1992-12-15

Family

ID=10623981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88114903T ATE82860T1 (de) 1987-09-18 1988-09-13 Thrombolytisches agens.

Country Status (11)

Country Link
EP (1) EP0307847B1 (de)
JP (1) JP2820699B2 (de)
AT (1) ATE82860T1 (de)
AU (1) AU623347B2 (de)
CA (1) CA1337046C (de)
DE (1) DE3876348T2 (de)
DK (1) DK518788A (de)
ES (1) ES2053658T3 (de)
GB (1) GB8721951D0 (de)
GR (1) GR3007194T3 (de)
NZ (1) NZ226217A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2764264B2 (ja) * 1987-10-01 1998-06-11 株式会社ミドリ十字 線溶活性増強剤
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
AT402263B (de) 1991-06-20 1997-03-25 Immuno Ag Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
WO1994001128A1 (en) * 1992-07-01 1994-01-20 Beth Israel Hospital Boston Enhancement of thrombolytic therapy with deglycosylated plasminogen
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel
US7202066B2 (en) 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
US11338022B2 (en) * 2015-12-18 2022-05-24 Talengen International Limited Method for preventing and treating angiocardiopathy
CN106890318A (zh) * 2015-12-18 2017-06-27 深圳瑞健生命科学研究院有限公司 一种预防和治疗糖尿病性心脏病的新方法
CN110191718A (zh) * 2016-12-15 2019-08-30 泰伦基国际有限公司 一种预防和治疗组织器官纤维化的方法
JP7168990B2 (ja) 2016-12-15 2022-11-10 タレンゲン インターナショナル リミテッド 肥満症を予防および治療するための方法および薬物
WO2018107703A1 (zh) 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种促进胰岛β细胞损伤修复和减少胰岛纤维化的方法
WO2018107690A1 (zh) 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种预防和治疗肥胖症的方法
EP3556385A4 (de) * 2016-12-15 2020-12-30 Talengen International Limited Verfahren zur verringerung von herzerkrankungen
JP7335609B2 (ja) 2017-06-19 2023-08-30 タレンゲン インターナショナル リミテッド Ｇｌｐ－１／ｇｌｐ－１ｒを調節制御する方法および薬剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504921A1 (fr) * 1981-04-30 1982-11-05 Choay Sa Medicament nouveau constitue par un complexe aprotinine-plasmine et procede de preparation de ce nouveau complexe
IL80166A0 (en) * 1985-10-01 1986-12-31 American Home Prod Method of enhancing t-pa and scu-pa production

Also Published As

Publication number Publication date
JPH0283335A (ja) 1990-03-23
JP2820699B2 (ja) 1998-11-05
DE3876348D1 (en) 1993-01-14
DK518788D0 (da) 1988-09-16
EP0307847A3 (en) 1990-03-07
DK518788A (da) 1989-03-19
AU623347B2 (en) 1992-05-14
GB8721951D0 (en) 1987-10-28
ES2053658T3 (es) 1994-08-01
AU2240088A (en) 1989-03-23
EP0307847B1 (de) 1992-12-02
GR3007194T3 (de) 1993-07-30
EP0307847A2 (de) 1989-03-22
CA1337046C (en) 1995-09-19
DE3876348T2 (de) 1993-06-09
NZ226217A (en) 1991-07-26

Similar Documents

Publication Publication Date Title
ATE82860T1 (de) Thrombolytisches agens.
ATE79252T1 (de) Zusammensetzung mit einem biologisch abbaubaren augenimplantat.
DK582188A (da) Stabile interferonkomplekser
DK463989A (da) Farmaceutisk virksom kombination
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
ATE72991T1 (de) Nasale verabreichung von arzneimitteln.
NO172344C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO864130D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
NO933235L (no) Anvendelse av en inhibitor for fremstilling av et medikament
ES2019634B3 (es) Terapia con clorfeniramina.
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO881884D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO882282D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazin-amider.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
ES279057U (es) Jeringuilla para inyecciones
DK301589D0 (da) Laegemiddel med thrombolytisk virkning
IT8722572A0 (it) Apparecchio medicale per iniezione controllata di medicinali.
NO870151L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-pyrimidinamider.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee